Clinical Research Guidelines for Treatment of Hyperlipidemia with New Uyghur Medicine (Draft)
10.3969/j.issn.1005-5304.2017.06.001
- VernacularTitle:维药新药治疗高脂血症的临床研究指导原则(草案)
- Author:
Abudukelimu ABUDUWAILI
;
Aibai SILAFU
;
Pingshan WANG
;
Wufuer ASIYA
;
Maitinuer YUSUFU
;
Wusiman MUHAMAITI
;
Maimaiti MAINISHA
;
Aximu TUERHONG
;
Hong ZHANG
;
Liansheng BAI
;
Jinfeng LI
;
Zhijian LI
;
Abuduaini ABUDUJILILI
;
Gongshu LI
;
Binglin LIU
;
Xiaojing PEI
;
Bei ZHOU
- Keywords:
hyperlipidemia;
Uyghur Medicine;
diagnostic techniques and methods;
clinical research guidelines
- From:
Chinese Journal of Information on Traditional Chinese Medicine
2017;24(6):1-5
- CountryChina
- Language:Chinese
-
Abstract:
Based on medical ethics, retrospective multi-center study on medical records of Uyghur Medicine diagnosis and treatment program of hyperlipidemia was done and demographic, diagnostic, therapeutic, efficacy evaluation, nursing data and other information were collated. The main and secondary disease manifestations of hyperlipidemia were analyzed inductively and hyperlipidemia were divided into 4 types in Uyghur Medicine field, which were surplus and sticky Kan type, Chuchumal Balgham type, Gaisiman Balgham type, and Koygan Savda type. Therefore, Uighur Medicine syndrome type standards of hyperlipidemia were established. Treatment efficacy was evaluated with the combination of laboratory observation parameters and main and secondary disease manifestations. On this basis, in accordance with the technical requirements of the national medicine review, this study developed clinical research guidelines for the treatment of hyperlipidemia with new Uyghur Medicine (draft).
